Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D4RGV9
|
|||
| Drug Name |
2-Ethoxypropanoic acid
|
|||
| Synonyms |
2-ethoxypropanoic acid; 53103-75-6; 2-ethoxypropionic acid; MFCD09940775; Propanoic acid, 2-ethoxy-; SCHEMBL142064; DTXSID00570733; 2-Ethoxypropanoic acid, AldrichCPR; STL508457; AKOS000184266; AKOS016903919; MCULE-2185795311; SY040144; DB-104575; EN300-39488; Y-6023
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65; ICD-10: C50, C79.51] | Preclinical | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H10O3
|
|||
| Canonical SMILES |
CCOC(C)C(=O)O
|
|||
| InChI |
1S/C5H10O3/c1-3-8-4(2)5(6)7/h4H,3H2,1-2H3,(H,6,7)
|
|||
| InChIKey |
XBHQOMRKOUANQQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 53103-75-6
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cryptochrome circadian clock 1 (CRY1) | Target Info | Inhibitor | [2] |
| Cryptochrome-2 (CRY2) | Target Info | Inhibitor | [2] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Circadian rhythm as a therapeutic target. Nat Rev Drug Discov. 2021 Apr;20(4):287-307. | |||
| REF 2 | The cryptochrome inhibitor KS15 enhances E-box-mediated transcription by disrupting the feedback action of a circadian transcription-repressor complex. Life Sci. 2018 May 1;200:49-55. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.